Abstract
Coronavirus disease 2019 (COVID-19) has caused more than 32 million cases and almost a million deaths. Recent reviews have evidenced the role of hypertension in prognosis, nevertheless, its association with immunosuppression in COVID-19 context has not been studied. It was performed a cross-sectional analysis of a large Mexican population with the infection (n= 681 890). Prevalence of immunosuppression and hypertension was 1.10% and 19.50%, respectively. The adjusted model evidenced that hypertension was significantly associated with immunosuppression (odds ratio=1.18, 95% CI=1.11-1.25). Further research in pathways that justify the association between hypertension and immunosuppression in COVID-19 patients is recommended.
Original language | English |
---|---|
Article number | em297 |
Journal | Electronic Journal of General Medicine |
Volume | 18 |
Issue number | 4 |
DOIs | |
State | Published - 2021 |
Keywords
- COVID-19
- Hypertension
- Mexico
- Public health
- Severe acute respiratory syndrome coronavirus 2